Since the proliferative and tumor stemness phenotypes were significantly affected by FAM64A inhibition, we next detected markers reflecting proliferation and cancer stemness, and found that the levels of PCNA, CD44, SOX2, and BMI-1 were all markedly decreased upon reduction of FAM64A (Fig. S3c). The gene discussed is CD44; the disease is cancer.